These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15724921)

  • 1. [The role of hypersympathycotony in development of arterial hypertension in patients with metabolic syndrome: potential of pathogenetically sound therapy].
    Ametov AS; Demidova TIu; Smagina LV
    Ter Arkh; 2004; 76(12):27-32. PubMed ID: 15724921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].
    Chazova IE; Mychka VB; Duishvili DE
    Ter Arkh; 2004; 76(8):28-32. PubMed ID: 15471392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tonocardin in complex treatment of diabetes mellitus concurrent with hypertension].
    Balabolkin MI; Khasanova ER; Trukhina TV; Kreminskaia VM
    Ter Arkh; 2002; 74(12):38-41. PubMed ID: 12577838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].
    Askerov MM
    Georgian Med News; 2009 Apr; (169):44-8. PubMed ID: 19430043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An AT-II blocker in patients with type II diabetes and arterial hypertension].
    Ametov AS; Demidova TIu; Kosykh SA
    Klin Med (Mosk); 2006; 84(2):50-5. PubMed ID: 16613007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of brerlipril in patients with non-insulin dependent diabetes mellitus and mild or moderate arterial hypertension as indicated by 24-h blood pressure monitoring].
    Ametov AS; Gubina EV; Nikolaev OG
    Ter Arkh; 1999; 71(8):17-20. PubMed ID: 10515028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
    Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
    Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective imidazoline agonist moxonidine in obese hypertensive patients.
    Sanjuliani AF; de Abreu VG; Francischetti EA
    Int J Clin Pract; 2006 May; 60(5):621-9. PubMed ID: 16700870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].
    Kobalava ZhD; Tolkacheva VV; Ignat'ev IV; Glezer MG; Kuzin AI; Karpov IuA; Konradi AO; Zheleznykh EA
    Ter Arkh; 2005; 77(1):46-51. PubMed ID: 15759454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
    Oren S; Turkot S; Paran E; Flandra O; Slezak L; Hof B
    J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of phisiotens for the treatment of arterial hypertension in elderly patients].
    Ostroumova OD; Mamaev VI; Bagramova IuA; Rybkina TE; Kuz'michev IA
    Ter Arkh; 2001; 73(9):17-22. PubMed ID: 11642073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [24-hour arterial hypertension profile and heart rhythm variability in patients with arterial hypertension and NIDDM].
    Borovkov NN; Sidorova NV
    Klin Med (Mosk); 2002; 80(7):19-21. PubMed ID: 12181808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of pharmacological blockade of angiotensin II type I receptors for correction of abnormal 24-hour blood pressure profile depending on its variability in patients with arterial hypertension stage II].
    Shustov SB; Barsukov AV; Al'-Iazidi MA; Kulikov AN; Konev AV
    Ter Arkh; 2002; 74(2):52-5. PubMed ID: 11899827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypotensive effect of 6-months cardiac rehabilitation in elderly patients].
    Kałka D; Sobieszczańska M; Marciniak W; Chorebała A; Markuszewski L; Metner E; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):95-100. PubMed ID: 17598651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
    Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
    Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of moxonidine in elderly patients with resistant hypertension.
    Martin U; Hill C; O' Mahony D
    J Clin Pharm Ther; 2005 Oct; 30(5):433-7. PubMed ID: 16164488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.